Team Type 1 Announces Internal Anti-Doping Testing Program
Scott Analytics is headed up by respected anti-doping researcher Paul Scott. He has previously served as Director of Clients at the UCLA Olympic Analytical Laboratory and Chief Scientific Officer and Chief Operating Officer of the Agency for Cycling Ethics, Inc.
Throughout the season, every athlete on the Team Type 1 men’s and women’s professional teams will be periodically tested in random controls – in addition to their participation in in-competition and out-of-competition tests administered by the United States Anti-Doping Agency (USADA) and the World Anti-Doping Agency (WADA).
Team Type 1 founder and second-year professional Phil Southerland said the new program is an integral part of the team’s core belief in fair play.
“The riders on Team Type 1 who have Type 1 diabetes – myself included – have to use insulin, not for racing, but to stay alive,” Southerland said.
Team Type 1's Dr. Michael Roshon will supervise the program. Roshon said three criteria were used for its inception: It had to be as effective as the biological passport program utilized by the International Cycling Union (UCI); it had to be independent, and it had to be within the scope of the team's budget.
"Our goal was to take those three criteria and come up with a program that is effective at detecting and deterring the use of performance enhancing substances," Roshon said.
Scott said Team Type 1's program marks a revolutionary step in the realm of anti-doping programs.
"Unlike other internal anti-doping programs – including ones I previously designed – this one will offer what the UCI requires of ProTour teams at a fraction of the cost," he said. "This is a complete program on a budget affordable to most U.S. or European continental teams."
